Department of Urology, Stanford School of Medicine, 300 Pasteur Dr., Room S-287, Stanford, California 94305, USA.
J Urol. 2011 Dec;186(6):2182-7. doi: 10.1016/j.juro.2011.07.106. Epub 2011 Oct 19.
Management for intraparenchymal renal tumors represents a technical challenge during laparoscopic partial nephrectomy since, unlike exophytic tumors, there are no external visual cues on the renal surface to guide tumor localization or excision. Also, hemostatic renorrhaphy and pelvicalyceal suture repair in these completely intrarenal tumors create additional challenges. We examined the safety and technical feasibility of this procedure in this cohort.
Of 800 patients who underwent laparoscopic partial nephrectomy 55 (6.9%) had completely intraparenchymal tumors. Technical steps included intraoperative ultrasound guidance of tumor resection, en bloc hilar clamping, cold excision of tumor and sutured renal reconstruction.
Mean tumor size was 2.3 cm (range 1.0 to 4.5), mean blood loss was 236 cc (range 25 to 1,000) and mean warm ischemia time was 29.9 minutes (range 7 to 57). There were no positive margins. When we compared laparoscopic partial nephrectomy for intraparenchymal tumors to the same procedure in another 3 tumor groups, including completely exophytic tumors, tumors infiltrating up to sinus fat and tumors infiltrating but not up to sinus fat, there were no statistically significant differences among the groups in complications, positive margin rate, blood loss, or tumor excision or warm ischemia time.
Laparoscopic partial nephrectomy for completely intrarenal tumors is a technically advanced but effective, safe procedure. Facility and experience with the technique, effective use of intracorporeal laparoscopic ultrasound and adherence to sound surgical principles are the keys to success. Most recently we have performed laparoscopic and robotic partial nephrectomy for such completely intrarenal tumors using a zero ischemia technique.
在腹腔镜肾部分切除术治疗肾实质内肿瘤时,由于与肾外生性肿瘤不同,肾脏表面没有外部可视线索来指导肿瘤定位或切除,因此管理存在技术挑战。此外,在这些完全位于肾内的肿瘤中进行止血性肾缝合和肾盂-肾盏缝合修复会带来额外的挑战。我们在此患者队列中检查了该手术的安全性和技术可行性。
在接受腹腔镜肾部分切除术的 800 例患者中,有 55 例(6.9%)肿瘤完全位于肾实质内。技术步骤包括术中超声引导肿瘤切除、整块肾门夹闭、冷切肿瘤和缝合肾重建。
平均肿瘤大小为 2.3cm(范围 1.0 至 4.5),平均失血量为 236cc(范围 25 至 1000),平均热缺血时间为 29.9 分钟(范围 7 至 57)。无阳性切缘。当我们将肾实质内肿瘤的腹腔镜肾部分切除术与另外 3 组肿瘤(包括完全外生性肿瘤、浸润至肾窦脂肪的肿瘤和浸润但未达肾窦脂肪的肿瘤)的同一手术进行比较时,在并发症、阳性切缘率、失血量或肿瘤切除或热缺血时间方面,各组之间无统计学差异。
腹腔镜肾部分切除术治疗完全位于肾内的肿瘤是一种技术先进但有效的安全手术。该技术的实施能力和经验、术中使用腔内腹腔镜超声以及坚持合理的手术原则是成功的关键。最近,我们使用无缺血技术对这些完全位于肾内的肿瘤进行了腹腔镜和机器人肾部分切除术。